GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inventionmed SA (WAR:INM) » Definitions » Beta

Inventionmed (WAR:INM) Beta : 0.34 (As of Dec. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Inventionmed Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-11), Inventionmed's Beta is 0.34.


Inventionmed Beta Historical Data

The historical data trend for Inventionmed's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventionmed Beta Chart

Inventionmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.74 - 0.49 0.81 0.87

Inventionmed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.87 0.83 0.95 0.88

Competitive Comparison of Inventionmed's Beta

For the Medical Devices subindustry, Inventionmed's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventionmed's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inventionmed's Beta distribution charts can be found below:

* The bar in red indicates where Inventionmed's Beta falls into.



Inventionmed Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Inventionmed  (WAR:INM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Inventionmed Beta Related Terms

Thank you for viewing the detailed overview of Inventionmed's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventionmed Business Description

Traded in Other Exchanges
N/A
Address
ul. Bydgoskich, Przemyslowcow 6, Bydgoszcz, POL, 85-862
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The firm's flagship project consists of TutorDerm, a simulator and an application that allow performing the activities necessary to treat specific dermatological conditions.

Inventionmed Headlines

From GuruFocus

InMed Announces Appointment of Chief Operating Officer

By PurpleRose PurpleRose 07-18-2022

InMed Submits Form 12b-25

By GlobeNewswire GlobeNewswire 02-10-2023

InMed Pharmaceuticals Inc Investor Summit Transcript

By GuruFocus Research 03-06-2024

InMed Announces Changes to its Board of Directors

By PurpleRose PurpleRose 08-09-2022

Q3 2021 InMed Pharmaceuticals Inc Earnings Call Transcript

By GuruFocus Research 03-06-2024

InMed Provides Business Update and Milestones for 2023

By Stock market mentor Stock market mentor 01-10-2023